Cancer Immunotherapeutic Potential of NKTT320, a Novel, Invariant, Natural Killer T Cell-Activating, Humanized Monoclonal Antibody

Invariant natural killer T cells (iNKTs) directly kill tumor cells and trans-activate the anti-tumor functions of dendritic cells (DC), natural killer (NK) cells, and T and B cells. As such, iNKTs serve as a powerful tool for use in cell-based cancer immunotherapy. iNKT cell activation commonly requ...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Nishant P., Guan, Peng, Bahal, Devika, Hashem, Tanwir, Scheuplein, Felix, Schaub, Robert, Nichols, Kim E., Das, Rupali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352964/
https://www.ncbi.nlm.nih.gov/pubmed/32560408
http://dx.doi.org/10.3390/ijms21124317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352964/
https://www.ncbi.nlm.nih.gov/pubmed/32560408
http://dx.doi.org/10.3390/ijms21124317

Ejemplares similares